Dhruv Satya Sahni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dhruv Satya Sahni has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
David B. Kingsmore
3 shared publicationsEmma Aitken
3 shared publicationsImran Ahmad
3 shared publicationsJohannes See Yi Xian
University Hospitals Nottingham NHS Trust
3 shared publicationsMehwash Nadeem
2 shared publicationsSrishti Ramsaha
College of Medical, Veterinary and Life Sciences, University of Glasgow, UK, G61 1BD
2 shared publications
Latest Publications
- 29 October 2026
- Published by Elsevier in European Urology Focus
Re: Nadia Bitar, Gabriella Howell, Ming He, et al. Bacterial Vaccines for Recurrent Urinary Tract Infections: A Systematic Review with Emerging Evidence in Kidney Transplant Recipients. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2026.06.022
- 29 October 2026
- Published by Elsevier in European Urology Focus
Re: Nadia Bitar, Gabriella Howell, Ming He, et al. Bacterial Vaccines for Recurrent Urinary Tract Infections: A Systematic Review with Emerging Evidence in Kidney Transplant Recipients. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2026.06.022
- 16 September 2026
- Published by Wiley in Neurourology and Urodynamics
Lower Urinary Tract Dysfunction in Renal Transplant Candidates: A Scoping Review of Assessment Methods and Post‐Transplant Urological Outcomes
Purpose: We performed a scoping review to map the available evidence regarding pre‐transplant lower urinary tract dysfunction (LUTD) assessment in adult renal transplant candidates and to summarise reported associations between pre‐transplant LUTD and post‐transplant urological outcomes. Methods: Electronic databases were searched up to 30th September 2025. Studies were included if they assessed lower urinary tract function prior to kidney transplantation using clinical history, questionnaires or investigations and reported post‐transplant urological complications and/or graft outcomes. Risk of bias was assessed using ROBINS‐I V2 for comparative studies and QUIPS for prognostic studies. Owing to substantial clinical and methodological heterogeneity, findings were synthesised narratively. Results: A total of 11 studies comprising 4471 patients met the inclusion criteria. Assessment strategies varied considerably across studies, ranging from clinical history alone to validated symptom questionnaires, uroflowmetry and urodynamic testing. Six studies reported urinary tract infection (UTI) outcomes, with most suggesting an increased risk in patients with pre‐transplant LUTD. Evidence for acute urinary retention and urosepsis was limited but directionally consistent with higher complication rates. Data on graft survival outcomes were sparse and heterogeneous, with some studies suggesting an association between pre‐transplant LUTD and poorer graft survival. Conclusions: Pre‐transplant LUTD appears to be associated with an increased risk of post‐transplant urological complications, particularly UTIs. However, the evidence is heterogeneous and largely observational, predominantly derived from retrospective studies, with limited data on graft outcomes. This scoping review highlights marked heterogeneity in pre‐transplant LUTD assessment and supports the development of a standardised assessment framework to guide future research and clinical practice.
- 16 September 2026
- Published by Wiley in Neurourology and Urodynamics
Lower Urinary Tract Dysfunction in Renal Transplant Candidates: A Scoping Review of Assessment Methods and Post‐Transplant Urological Outcomes
Purpose: We performed a scoping review to map the available evidence regarding pre‐transplant lower urinary tract dysfunction (LUTD) assessment in adult renal transplant candidates and to summarise reported associations between pre‐transplant LUTD and post‐transplant urological outcomes. Methods: Electronic databases were searched up to 30th September 2025. Studies were included if they assessed lower urinary tract function prior to kidney transplantation using clinical history, questionnaires or investigations and reported post‐transplant urological complications and/or graft outcomes. Risk of bias was assessed using ROBINS‐I V2 for comparative studies and QUIPS for prognostic studies. Owing to substantial clinical and methodological heterogeneity, findings were synthesised narratively. Results: A total of 11 studies comprising 4471 patients met the inclusion criteria. Assessment strategies varied considerably across studies, ranging from clinical history alone to validated symptom questionnaires, uroflowmetry and urodynamic testing. Six studies reported urinary tract infection (UTI) outcomes, with most suggesting an increased risk in patients with pre‐transplant LUTD. Evidence for acute urinary retention and urosepsis was limited but directionally consistent with higher complication rates. Data on graft survival outcomes were sparse and heterogeneous, with some studies suggesting an association between pre‐transplant LUTD and poorer graft survival. Conclusions: Pre‐transplant LUTD appears to be associated with an increased risk of post‐transplant urological complications, particularly UTIs. However, the evidence is heterogeneous and largely observational, predominantly derived from retrospective studies, with limited data on graft outcomes. This scoping review highlights marked heterogeneity in pre‐transplant LUTD assessment and supports the development of a standardised assessment framework to guide future research and clinical practice.
- Open Access
- 24 June 2026
- Published by Taylor & Francis in Arab Journal of Urology
- p. 1-12
Effect of music on pain and anxiety during cystoscopy: A systematic review and meta-analysis of randomised controlled trials
Cystoscopy is the most commonly performed outpatient urological procedure and is used to visualise the lower urinary tract for a wide range of diagnostic and therapeutic indications. Although techn...
- 24 June 2026
- Published by Taylor & Francis in Arab Journal of Urology
- p. 1-12
Open AccessEffect of music on pain and anxiety during cystoscopy: A systematic review and meta-analysis of randomised controlled trials
Cystoscopy is the most commonly performed outpatient urological procedure and is used to visualise the lower urinary tract for a wide range of diagnostic and therapeutic indications. Although techn...
- Open Access
- 16 March 2026
- Published by Canadian Urological Association Journal in Canadian Urological Association Journal
- Vol. 20 (7) , E301
Conflicting evidence and methodological concerns in recent meta-analyses of tranexamic acid in radical cystectomy
- 16 March 2026
- Published by Canadian Urological Association Journal in Canadian Urological Association Journal
- Vol. 20 (7) , E301
Open AccessConflicting evidence and methodological concerns in recent meta-analyses of tranexamic acid in radical cystectomy
- Open Access
- 1 January 2021
- Published by Medknow in Indian Journal of Community Medicine
- Vol. 46 (3) , 380-388
A systematic review on the therapeutic relevance of hydroxychloroquine/chloroquine in the management of COVID-19
. This systematic review highlights the efficacy of chloroquine and its derivative hydroxychloroquine in the treatment of COVID-19 and also explores the safety profile of these drugs. Methods: EMBASE, COCHRANE, and PubMed databases were searched for studies on the use of hydroxychloroquine or chloroquine in the treatment of COVID-19. Results: Twenty articles were selected including expert opinions, National Guidelines, three small randomized controlled trials, and one prospective study. Both hydroxychloroquine and chloroquine have shown promising results including reduction in hospital length of stay and overall mortality. Moreover, concomitant use with azithromycin seems to reduce viral load to a greater extent. Conclusions: Considering the known safety profile of these drugs in the treatment of other diseases, their availability and affordability, chloroquine and hydroxychloroquine are potential antiviral agents in the treatment of COVID-19. However, reported side effects of these drugs when used in conjunction with azithromycin in patients with comorbidities have raised significant safety concerns. High-quality randomized clinical trials are warranted to provide more comprehensive evidence of the safety of these drugs in patients infected with COVID-19....
- 1 January 2021
- Published by Medknow in Indian Journal of Community Medicine
- Vol. 46 (3) , 380-388
Open AccessA systematic review on the therapeutic relevance of hydroxychloroquine/chloroquine in the management of COVID-19
. This systematic review highlights the efficacy of chloroquine and its derivative hydroxychloroquine in the treatment of COVID-19 and also explores the safety profile of these drugs. Methods: EMBASE, COCHRANE, and PubMed databases were searched for studies on the use of hydroxychloroquine or chloroquine in the treatment of COVID-19. Results: Twenty articles were selected including expert opinions, National Guidelines, three small randomized controlled trials, and one prospective study. Both hydroxychloroquine and chloroquine have shown promising results including reduction in hospital length of stay and overall mortality. Moreover, concomitant use with azithromycin seems to reduce viral load to a greater extent. Conclusions: Considering the known safety profile of these drugs in the treatment of other diseases, their availability and affordability, chloroquine and hydroxychloroquine are potential antiviral agents in the treatment of COVID-19. However, reported side effects of these drugs when used in conjunction with azithromycin in patients with comorbidities have raised significant safety concerns. High-quality randomized clinical trials are warranted to provide more comprehensive evidence of the safety of these drugs in patients infected with COVID-19....